← SynDRA
CETILISTAT
SynDRA canonical compound SYN0030030 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | LIPC | LIPE | LIPG | PNLIP |
|---|
| Mechanism of action | triacylglycerol lipase inhibitor |
|---|
All known targets
- PNLIP
- LIPF
- LIPC
- LIPE
- LIPG
- Pnlip
Mechanisms of action (all sources)
- PNLIP INHIBITOR
- Pancreatic lipase inhibitor
- LIPF INHIBITOR
- Gastric lipase inhibitor
- triacylglycerol lipase inhibitor
- LIPF MODULATOR
Drug classes
- Anti-Obesity Agents
- Enzyme Inhibitors
- Lipid Regulating Agents
Cross-references
Synonyms
- ATL-962
- oblean
- Cametor
- Cetilistat [INN]
- ATL962
- Cetilistat (JAN/USAN/INN)
- 2-(Hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one
- ATL 962
- 4H-3,1-Benzoxazin-4-one, 2-(hexadecyloxy)-6-methyl-
- 2-hexadecoxy-6-methyl-3,1-benzoxazin-4-one
- LC5G1JUA39
- cetilistatum
- RefChem:575350
- DTXCID60104997
- MFCD09839697
- 2-(hexadecyloxy)-6-methyl-4H-benzo[d][1,3]oxazin-4-one
- Citilistat
- 2-Hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one
- UNII-LC5G1JUA39
- Cetilistat [USAN:INN:BAN:JAN]
- Oblean (TN)
- CETILISTAT [MI]
- CETILISTAT [JAN]
- CETILISTAT [USAN]
- CETILISTAT [WHO-DD]
- SCHEMBL367612
- Cetilistat - Bio-X trade mark
- orb1304348
- SCHEMBL29352962
- GTPL11433
- EX-A983
- MSK1610
- CHEBI:134721
- MVCQKIKWYUURMU-UHFFFAOYSA-N
- GLXC-06700
- HMS3873M13
- HMS5087D14
- AC-219
Look up CETILISTAT in the interactive SynDRA portal →